T

Tempest Therapeutics
D

TPST

10.210
USD
-0.61
(-5.60%)
مغلق
حجم التداول
0
الربح لكل سهم
-13
العائد الربحي
-
P/E
-1
حجم السوق
45,334,044
الأخبار المقالات

العنوان: Tempest Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.